PLEXUS Trademark

Trademark Overview


On Monday, December 22, 2014, a trademark application was filed for PLEXUS with the United States Patent and Trademark Office. The USPTO has given the PLEXUS trademark a serial number of 79171662. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, July 11, 2022. This trademark is owned by Vascutek Limited. The PLEXUS trademark is filed in the Medical Instrument Products category with the following description:

Surgical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease, namely, thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched graf...
plexus

General Information


Serial Number79171662
Word MarkPLEXUS
Filing DateMonday, December 22, 2014
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, July 11, 2022
Registration Number5024473
Registration DateTuesday, August 23, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2016

Trademark Statements


Goods and ServicesSurgical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease, namely, thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, namely, surgical mesh comprised primarily of prosthetic materials; medical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease; grafts, namely, prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; stents, patches, namely, patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; prostheses, namely, artificial surgical prostheses; surgical implants comprising artificial material; suture materials; patches for repair and reconstruction of internal tissue, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, synthetic heart valve conduits, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; artificial vascular grafts; artificial endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease medical devices for use in endovascular procedures for treating cardiovascular disease; stents; thoracic stents; artificial thoracic stent grafts; thoracic stent graft systems comprising synthetic stent grafts and stent delivery systems; delivery systems for stent graft systems comprising stent delivery systems; aneurysm repair systems comprised of catheter delivered artificial stent grafts and stent delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems comprised of artificial cardiac valves; artificial heart valves; heart valve conduits namely, catheters for implanting heart valves; cardiac patches and vascular patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 4, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVascutek Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRenfrewshire PA4 9RR
GB

Party NameVascutek Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameVascutek Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, July 11, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, July 11, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, June 6, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 21, 2021TEAS SECTION 71 & 15 RECEIVED
Monday, August 23, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 17, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 19, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 19, 2017FINAL DISPOSITION PROCESSED
Wednesday, November 23, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 23, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, July 28, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, June 7, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 1, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 18, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 30, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 29, 2016ASSIGNED TO LIE
Thursday, April 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 28, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, April 28, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 28, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, April 28, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 29, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 29, 2016ASSIGNED TO LIE
Tuesday, March 15, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 15, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 2, 2015REFUSAL PROCESSED BY IB
Tuesday, September 15, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 15, 2015REFUSAL PROCESSED BY MPU
Saturday, September 12, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 11, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 8, 2015APPLICATION FILING RECEIPT MAILED
Friday, September 4, 2015ASSIGNED TO EXAMINER
Friday, September 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 3, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB